Ad is loading...
GFAFX
Price
$80.89
Change
+$0.46 (+0.57%)
Updated
Nov 22 closing price
LGLSX
Price
$47.83
Change
-$0.05 (-0.10%)
Updated
Nov 22 closing price
Ad is loading...

GFAFX vs LGLSX

Header iconGFAFX vs LGLSX Comparison
Open Charts GFAFX vs LGLSXBanner chart's image
American Funds Growth Fund of Amer F1
Price$80.89
Change+$0.46 (+0.57%)
VolumeN/A
CapitalizationN/A
Lord Abbett Growth Leaders R4
Price$47.83
Change-$0.05 (-0.10%)
VolumeN/A
CapitalizationN/A
GFAFX vs LGLSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFAFX vs. LGLSX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongSell and LGLSX is a Buy.

FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 302B vs. LGLSX (7.25B). GFAFX pays higher dividends than LGLSX: GFAFX (0.45) vs LGLSX (0.00). GFAFX was incepted earlier than LGLSX: GFAFX (24 years) vs LGLSX (9 years). LGLSX is a more actively managed with annual turnover of: 120.00 vs. GFAFX (31.00). LGLSX has a lower initial minimum investment than GFAFX: LGLSX (0) vs GFAFX (250). LGLSX annual gain was more profitable for investors over the last year : 51.84 vs. GFAFX (28.83). LGLSX return over 5 years is better than : 75.07 vs. GFAFX (56.09).
GFAFXLGLSXGFAFX / LGLSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD29.19746.35963%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets302B7.25B4,167%
Annual Yield % from dividends0.450.00-
Returns for 1 year28.8351.8456%
Returns for 3 years0.3511.993%
Returns for 5 years56.0975.0775%
Returns for 10 years72.42N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTEN8.680.32
+3.83%
Patterson-UTI Energy
GHM44.651.30
+3.00%
Graham Corp
DOW45.460.65
+1.45%
Dow
LEXX2.09-0.07
-3.24%
Lexaria Bioscience Corp
SAVA26.48-5.70
-17.71%
Cassava Sciences